証拠の内容は英語で管理されます。

Bottom line

"Focus, Stress & Sleep Blend" is a clinic-marketed name for a Semax + Selank + DSIP mixture. The identified listing claims a 10/10/2 mg composition, but a single clinic formulation does not define a standard. No published study of this exact three-component combination was identified.

No established or recommended human dose. The claimed 10/10/2 amount is a market observation, not guidance.

Name and formulation variability

Observed source/dateClaimed componentsClaimed amountsVerification limits
Beverly Hills Rejuvenation Center (2026)Semax, Selank, DSIP10 / 10 / 2 mgClinic-declared market observation; identity and contents not independently verified

Only one named formulation was identified. That is insufficient to establish either multi-vendor standardization or a stable market definition.

Component evidence

ComponentSeparate evidenceEvidence for combinationCompatibility/stability evidence
SemaxSee component monographNone identified for this three-component setNone identified
SelankSee component monographNone identified for this three-component setNone identified
DSIPSee component monographNone identified for this three-component setNone identified

Combination-specific studies

No published peer-reviewed study testing the exact Semax + Selank + DSIP mixture was identified. The clinic page documents a marketed formulation only.

Safety and interaction uncertainties

  • No combination-specific human safety, interaction, , or toxicology data were identified.

  • A three-component mixture complicates attribution of any unexpected effect.

  • Identity, purity, sterility, and co-formulation stability cannot be inferred from clinic marketing.

  • The stability of the three peptides together was not established by the supplied source.

Regulatory and product-quality notes

  • "Focus, Stress & Sleep Blend" is not a regulatory or pharmacopoeial formulation name.

  • A clinic listing is low-quality evidence for market observation and does not establish efficacy, safety, approval, or product quality.

  • Exact product and jurisdiction must be evaluated separately from the marketing name.

Evidence gaps

  • No second independent formulation source

  • No controlled combination study

  • No independent identity or content verification

  • No published compatibility or stability data

Sources

  1. Beverly Hills Rejuvenation Center. Semax, Selank & DSIP Blend clinic page. https://bhrcenter.com/peptides/semax-selank-dsip-blend/ accessed 2026-08-08.

  2. Beverly Hills Rejuvenation Center. Peptide services overview. https://bhrcenter.com/peptides/ accessed 2026-08-08.

専門家の声

専門家の見解

コメントは個人の見解であり、エビデンスレビューの一部ではありません。掲載は支持を意味しません。

この化合物について、本アトラスが受け入れる情報源 — 査読付き文献、大学・病院・医学会の発表、規制当局、署名入りサイエンスジャーナリズム — において、検証済みの専門家コメントは見つかりませんでした。

コメントがないことは、化合物に関するいずれの方向の証拠にもなりません。

ベンダー、クリニック、ソーシャルメディアの主張はポリシーにより除外され、コメントとしてカウントされません。

この化合物について、本アトラスの情報源において検証済みの専門家ビデオは見つかりませんでした。

ビデオコメントがないことは、化合物に関するいずれの方向の証拠にもなりません。

ベンダーとソーシャルメディアのビデオはポリシーにより除外され、カウントされません。

質問

What is in the Focus, Stress & Sleep Blend?

The identified clinic listing names Semax, Selank, and DSIP. That listing documents one claimed formulation, not a general market standard.

Is the Semax, Selank, and DSIP mixture standardized?

No. Only one named clinic formulation was identified, which is insufficient to establish a stable definition or independent corroboration.

Has the exact Focus, Stress & Sleep combination been studied?

No published peer-reviewed study testing the exact three-component mixture was identified. The clinic page is a market observation, not research evidence.

Can evidence for Semax, Selank, or DSIP validate the mixture?

No. Separate component findings cannot establish the safety, compatibility, interactions, or performance of the combined product.

What product-quality questions remain for this three-component blend?

Independent evidence for identity, content, purity, sterility, compatibility, and co-formulation stability was not identified.